Health News from Medical News Today: AstraZeneca And Heptares Collaborate To Investigate Important GPCR Drug Targets

Health News from Medical News Today Latest Health News and Medical News posted throughout the day, every day. AstraZeneca And Heptares Collaborate To Investigate Important GPCR Drug Targets 31 May 2011, 4:00 pm AstraZeneca and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors (GPCRs). GPCRs are among the largest and most important family of proteins found in the human body, yet they become highly unstable when removed from their natural membrane-bound environments. This instability has prevented pharmaceutical researchers from understanding GPCR structures and hampered efforts to design medicines that work on GPCR targets... You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed.